Instil Bio (TIL) Total Liabilities (2020 - 2026)
Instil Bio (TIL) posted quarterly Total Liabilities of $89.7 million for Q1 2026, down 3.03% year-over-year from $92.5 million in Q1 2025, and little changed quarter-over-quarter from $89.7 million in Q4 2025.
Instil Bio (TIL) Total Liabilities (2020 - 2026) Analysis & Trends
Instil Bio's Total Liabilities history runs 7 years deep, the most recent figure standing at $89.7 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 3.03% year-over-year to $89.7 million; the TTM figure through Mar 2026 stood at $89.7 million (down 3.03% YoY), while the FY2025 annual figure was $89.7 million, down 4.75% from the prior year.
- Total Liabilities for Q1 2026 stood at $89.7 million, roughly flat from $89.7 million in the prior quarter.
- The five-year high for Total Liabilities was $122.2 million in Q3 2022, with the low at $56.4 million in Q1 2022.
- The 5-year median for Total Liabilities is $99.3 million (2025), against an average of $99.6 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities soared 196.26% in 2022, then declined 15.8% in 2023.
- Instil Bio's Total Liabilities stood at $118.5 million in 2022, then decreased by 15.8% to $99.8 million in 2023, then dropped by 5.68% to $94.1 million in 2024, then declined by 4.75% to $89.7 million in 2025, then advanced by 0.08% to $89.7 million in 2026.
- Business Quant data shows TIL's Total Liabilities at $89.7 million in Q1 2026, $89.7 million in Q4 2025, and $91.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 90.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.33 Mn |
| Mar 31, 2026 | 89.73 Mn |
| Dec 31, 2025 | 89.66 Mn |
| Sep 30, 2025 | 91.35 Mn |
| Jun 30, 2025 | 99.32 Mn |
| Mar 31, 2025 | 92.54 Mn |
| Dec 31, 2024 | 94.13 Mn |
| Sep 30, 2024 | 96.23 Mn |
| Jun 30, 2024 | 99.30 Mn |
| Mar 31, 2024 | 100.48 Mn |
| Dec 31, 2023 | 99.80 Mn |
| Sep 30, 2023 | 106.25 Mn |
| Jun 30, 2023 | 111.79 Mn |
| Mar 31, 2023 | 116.02 Mn |
| Dec 31, 2022 | 118.52 Mn |
| Sep 30, 2022 | 122.15 Mn |
| Jun 30, 2022 | 110.20 Mn |
| Mar 31, 2022 | 56.38 Mn |
| Dec 31, 2021 | 54.78 Mn |
| Sep 30, 2021 | 45.98 Mn |